A U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, giving Amneal Pharmaceuticals Inc a boost in its effort to launch a generic version of the medicine.

https://in.reuters.com/article/us-jazz-amneal-patent/u-s-court-denies-jazz-pharma-bid-to-revive-narcolepsy-drug-patents-idINKBN1K326D